first-line treatment

Ipilimumab-nivolumab combination improves overall survival in metastatic kidney cancer

By Sharon Kell|2018-03-26T09:27:33+00:0026 Mar 2018|Drug treatments|

Overall survival data for the ipilimumab-nivolumab combination versus sunitinib from [...]

Comments Off

First-line immunotherapy for metastatic kidney cancer

By Sharon Kell|2018-02-20T14:31:50+00:0020 Feb 2018|Drug treatments|

The following is a Practice Update interview with Dr Eric [...]

Comments Off

US Food and Drug Administration approves frontline cabozantinib for advanced kidney cancer

By Sharon Kell|2017-12-20T08:34:43+00:0020 Dec 2017|Drug treatments|

Cabozantinib (Cabometyx) has been granted approval by the US Food [...]

Comments Off

First-line treatment for metastatic kidney cancer – an interview with Dr Eric Jonasch

By Sharon Kell|2017-11-06T11:55:09+00:006 Nov 2017|Drug treatments|

The following is an interview with Dr Eric Jonasch, Professor [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org